D. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.49, issue.1, pp.74-108, 2002.
DOI : 10.3322/canjclin.49.1.33

S. Baxi, D. Sher, and D. Pfister, Value Considerations in the Treatment of Head and Neck Cancer: Radiation, Chemotherapy, and Supportive Care, American Society of Clinical Oncology Educational Book, vol.34, pp.296-303
DOI : 10.14694/EdBook_AM.2014.34.e296

S. Singer, J. Langendijk, and N. Yarom, Assessing and Improving Quality of Life in Patients with Head and Neck Cancer, American Society of Clinical Oncology Educational Book, vol.33
DOI : 10.1200/EdBook_AM.2013.33.e230

S. Ghosh-laskar, P. Yathiraj, D. Dutta, V. Rangarajan, N. Purandare et al., Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results, Head & Neck, vol.82, issue.S1, pp.1481-1487, 2016.
DOI : 10.1016/j.ijrobp.2010.10.061

B. Fertil and E. Malaise, Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.7, issue.5, pp.621-630, 1981.
DOI : 10.1016/0360-3016(81)90377-1

N. Chavaudra, J. Bourhis, and N. Foray, Quantified relationship between cellular radiosensitivity, DNA repair defects and chromatin relaxation: a study of 19 human tumour cell lines from different origin, Radiotherapy and Oncology, vol.73, issue.3, pp.373-82, 2004.
DOI : 10.1016/j.radonc.2004.07.016

URL : https://hal.archives-ouvertes.fr/inserm-00388960

H. Skinner, U. Giri, L. Yang, S. Woo, M. Story et al., Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer, Clinical Cancer Research, vol.22, issue.18, pp.4643-50, 2016.
DOI : 10.1158/1078-0432.CCR-15-2785

J. Hall, R. Iype, J. Senra, J. Taylor, L. Armenoult et al., Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines, PLoS ONE, vol.123, issue.1, p.86329, 2014.
DOI : 10.1371/journal.pone.0086329.s015

F. Jerhammar, R. Ceder, S. Garvin, R. Grenman, R. Grafstrom et al., Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma, Cancer Biology & Therapy, vol.10, issue.12, pp.1244-51, 2010.
DOI : 10.4161/cbt.10.12.13432

J. Pramana, M. Van-den-brekel, M. Van-velthuysen, L. Wessels, D. Nuyten et al., Gene Expression Profiling to Predict Outcome After Chemoradiation in Head and Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.5, pp.1544-52, 2007.
DOI : 10.1016/j.ijrobp.2007.08.032

D. De-ridder, C. Van-der-linden, T. Schonewille, W. Dik, M. Reinders et al., Purity for clarity: the need for purification of tumor cells in DNA microarray studies, Leukemia, vol.114, issue.4, pp.618-645, 2005.
DOI : 10.1073/pnas.2536479100

K. Yoshihara, M. Shahmoradgoli, E. Martinez, R. Vegesna, H. Kim et al., Inferring tumour purity and stromal and immune cell admixture from expression data, Nature Communications, vol.57, p.2612, 2013.
DOI : 10.1016/j.cell.2012.08.029

URL : http://www.nature.com/articles/ncomms3612.pdf

D. Aran, M. Sirota, and A. Butte, Systematic pan-cancer analysis of tumour purity, Nature Communications, vol.7, p.8971, 2015.
DOI : 10.1371/journal.pone.0041361

K. Lindel, K. Beer, J. Laissue, R. Greiner, and D. Aebersold, Human papillomavirus positive squamous cell carcinoma of the oropharynx, Cancer, vol.18, issue.4, pp.805-818, 2001.
DOI : 10.1038/sj.onc.1202818

H. Mirghani, F. Amen, Y. Tao, E. Deutsch, and A. Levy, Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives, Cancer Treatment Reviews, vol.41, issue.10, pp.844-52, 2015.
DOI : 10.1016/j.ctrv.2015.10.001

C. Fakhry, W. Westra, S. Li, A. Cmelak, J. Ridge et al., Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial, JNCI Journal of the National Cancer Institute, vol.100, issue.4, pp.261-270, 2008.
DOI : 10.1093/jnci/djn011

L. Masterson, D. Moualed, Z. Liu, J. Howard, R. Dwivedi et al., De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis of current clinical trials, European Journal of Cancer, vol.50, issue.15, pp.2636-2684, 2014.
DOI : 10.1016/j.ejca.2014.07.001

H. Mirghani, F. Amen, P. Blanchard, F. Moreau, J. Guigay et al., Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives, International Journal of Cancer, vol.18, issue.7, pp.1494-503, 2015.
DOI : 10.1158/1078-0432.CCR-11-2824

URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.28847/pdf

A. Jung, S. Guihard, S. Krugell, S. Ledrappier, A. Brochot et al., CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis, International Journal of Cancer, vol.14, issue.2, pp.26-36, 2013.
DOI : 10.1158/1078-0432.CCR-07-1880

T. Pawlik and K. Keyomarsi, Role of cell cycle in mediating sensitivity to radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.4, pp.928-970, 2004.
DOI : 10.1016/j.ijrobp.2004.03.005

A. Jedlinski, A. Ansell, A. Johansson, and K. Roberg, EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines, Journal of Oral Pathology & Medicine, vol.6, issue.1, pp.26-36, 2013.
DOI : 10.1097/JTO.0b013e31823ab0dd

F. Perri, R. Pacelli, D. V. Scarpati, G. Cella, L. Giuliano et al., Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications, Head & Neck, vol.13, issue.1, pp.763-70, 2015.
DOI : 10.1186/1471-2407-13-26

M. Jong, T. Hoeve, J. Grenman, R. Wessels, L. Kerkhoven et al., Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients, Clinical Cancer Research, vol.21, issue.24, pp.5630-5638, 2015.
DOI : 10.1158/1078-0432.CCR-15-0454

C. Chung, J. Parker, G. Karaca, J. Wu, W. Funkhouser et al., Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression, Cancer Cell, vol.5, issue.5, pp.489-500, 2004.
DOI : 10.1016/S1535-6108(04)00112-6

V. Walter, X. Yin, M. Wilkerson, C. Cabanski, N. Zhao et al., Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes, PLoS ONE, vol.27, issue.5, p.56823, 2013.
DOI : 10.1371/journal.pone.0056823.s017

U. Shankavaram, S. Varma, D. Kane, M. Sunshine, K. Chary et al., CellMiner: a relational database and query tool for the NCI-60 cancer cell lines, BMC Genomics, vol.10, issue.1, p.277, 2009.
DOI : 10.1186/1471-2164-10-277

W. Reinhold, M. Sunshine, H. Liu, S. Varma, K. Kohn et al., CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set, Cancer Research, vol.72, issue.14, pp.3499-511, 2012.
DOI : 10.1158/0008-5472.CAN-12-1370

S. Amundson, K. Do, L. Vinikoor, R. Lee, C. Koch-paiz et al., Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen, Cancer Research, vol.68, issue.2, pp.415-439, 2008.
DOI : 10.1158/0008-5472.CAN-07-2120

H. Kim, S. Kim, S. Kim, C. Park, H. Jeung et al., Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells, BMC Genomics, vol.13, issue.1, p.348, 2012.
DOI : 10.1186/1471-2164-13-348

W. Yang, J. Soares, P. Greninger, E. Edelman, H. Lightfoot et al., Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells, Nucleic Acids Research, vol.41, issue.D1, pp.955-961, 2013.
DOI : 10.1093/nar/gks1111

Y. Wan, G. Allen, and Z. Liu, TCGA2STAT: simple TCGA data access for integrated statistical analysis in R, Bioinformatics, vol.32, issue.6, pp.952-956, 2016.
DOI : 10.1093/bioinformatics/btv677

B. Institute, T. Genome-data-analysis, and . Center, Mutation Analysis (MutSig v2.0), Broad Institute of MIT and Harvard. 2016. doi:10.7908/C1D21X1G. 35. Broad Institute TCGA Genome Data Analysis Center: SNP6 Copy number analysis (GISTIC2), Broad Institute of

C. Mermel, S. Schumacher, B. Hill, M. Meyerson, R. Beroukhim et al., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers, Genome Biology, vol.12, issue.4, p.41, 2011.
DOI : 10.1214/aos/1176344136

E. Cerami, J. Gao, U. Dogrusoz, B. Gross, S. Sumer et al., The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1., Cancer Discovery, vol.2, issue.5, pp.401-405, 2012.
DOI : 10.1158/2159-8290.CD-12-0095

J. Gao, B. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross et al., Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal, Science Signaling, vol.26, issue.18, p.1, 2013.
DOI : 10.1093/bioinformatics/btq430

J. Li, Y. Lu, R. Akbani, Z. Ju, P. Roebuck et al., TCPA: a resource for cancer functional proteomics data, Nature Methods, vol.10, issue.11, pp.1046-1053, 2013.
DOI : 10.1038/nbt1210-1248

URL : http://www.nature.com/nmeth/journal/v10/n11/pdf/nmeth.2650.pdf

M. Kuriakose, W. Chen, Z. He, A. Sikora, P. Zhang et al., Selection and validation of differentially expressed genes in head and neck cancer, Cellular and Molecular Life Sciences (CMLS), vol.61, issue.11, pp.611372-83, 2004.
DOI : 10.1007/s00018-004-4069-0

G. Wichmann, M. Rosolowski, K. Krohn, M. Kreuz, A. Boehm et al., mutations in diagnostic and prognostic profiling of head and neck cancer, International Journal of Cancer, vol.132, issue.12, pp.2846-57, 2015.
DOI : 10.1002/ijc.27906

D. Barbie, P. Tamayo, J. Boehm, S. Kim, S. Moody et al., Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, vol.98, issue.7269, pp.108-120, 2009.
DOI : 10.4049/jimmunol.167.9.4948

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783335

A. Subramanian, P. Tamayo, V. Mootha, S. Mukherjee, B. Ebert et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.19, issue.18, pp.15545-50, 2005.
DOI : 10.1093/bioinformatics/btg363

URL : http://www.pnas.org/content/102/43/15545.full.pdf

A. Liberzon, C. Birger, H. Thorvaldsdottir, M. Ghandi, J. Mesirov et al., The Molecular Signatures Database Hallmark Gene Set Collection, Cell Systems, vol.1, issue.6, pp.417-442, 2015.
DOI : 10.1016/j.cels.2015.12.004

URL : http://doi.org/10.1016/j.cels.2015.12.004

S. Dudoit, R. Gentleman, and J. Quackenbush, Open source software for the analysis of microarray data, Biotechniques, pp.45-51, 2003.

M. Reich, T. Liefeld, J. Gould, J. Lerner, P. Tamayo et al., GenePattern 2.0, Nature Genetics, vol.4, issue.5, pp.500-501, 2006.
DOI : 10.1126/science.286.5439.531

M. Marcu, M. Doyle, A. Bertolotti, D. Ron, L. Hendershot et al., Heat Shock Protein 90 Modulates the Unfolded Protein Response by Stabilizing IRE1??, Molecular and Cellular Biology, vol.22, issue.24, pp.8506-8519, 2002.
DOI : 10.1128/MCB.22.24.8506-8513.2002

URL : http://mcb.asm.org/content/22/24/8506.full.pdf

E. Born, S. Hartman, and S. Holstein, Targeting HSP90 and monoclonal protein trafficking modulates the unfolded protein response, chaperone regulation and apoptosis in myeloma cells, Blood Cancer Journal, vol.261, issue.12, p.167, 2013.
DOI : 10.1006/mthe.2002.0639

K. Wong, G. Delaney, and M. Barton, Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand, Radiotherapy and Oncology, vol.119, issue.1, pp.145-154, 2016.
DOI : 10.1016/j.radonc.2015.12.001

S. Eschrich, J. Pramana, H. Zhang, H. Zhao, D. Boulware et al., A Gene Expression Model of Intrinsic Tumor Radiosensitivity: Prediction of Response and Prognosis After Chemoradiation, International Journal of Radiation Oncology*Biology*Physics, vol.75, issue.2, pp.489-96, 2009.
DOI : 10.1016/j.ijrobp.2009.06.014

C. Hetz, E. Chevet, and H. Harding, Targeting the unfolded protein response in disease, Nature Reviews Drug Discovery, vol.11, issue.9, pp.703-722, 2013.
DOI : 10.1016/j.ccr.2007.02.015